Anxiety Disorders Completed Phase 4 Trials for Aripiprazole (DB01238)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00208169Abilify Therapy for Reducing Comorbid Substance AbuseTreatment